CVS - CVS Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
73.59
-0.67 (-0.90%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close74.26
Open74.22
Bid73.51 x 900
Ask74.00 x 1100
Day's Range73.58 - 74.54
52 Week Range51.72 - 77.03
Volume3801102
Avg. Volume6,802,063
Market Cap96B
Beta (5Y Monthly)0.88
PE Ratio (TTM)20.73
EPS (TTM)3.55
Earnings DateFeb 18, 2020 - Feb 24, 2020
Forward Dividend & Yield2.00 (2.69%)
Ex-Dividend Date2019-10-23
1y Target Est79.74
  • Broadway restaurant closed, site to be redeveloped
    American City Business Journals

    Broadway restaurant closed, site to be redeveloped

    A longstanding fast food restaurant at Preston and Broadway in downtown Louisville will soon be removed. CVS Health Corp. has scooped up several parcels in the 400 block of East Broadway where it is planning to construct a nearly 10,000-square-foot pharmacy and retail store, according to plans filed with Louisville Metro Government. The filings state that the roughly 9,600-square-foot store will be located at 400 E. Broadway, where a Long John Silver’s restaurant has long resided.

  • UPDATE 1-CVS to increase genetic testing for some cancer patients
    Reuters

    UPDATE 1-CVS to increase genetic testing for some cancer patients

    CVS Health Corp said on Thursday it will make it easier for patients with advanced cancer enrolled in some Aetna insurance plans to receive broad genetic gene sequencing tests that can help identify the best drug or treatment for them. CVS has been running an oncology program in 12 states in which patients prescribed treatment regimens that follow National Comprehensive Cancer Network guidelines automatically receive prior authorization approval, speeding the time to starting their treatment. It will now add easier access to broad-panel gene sequencing tests to that program for patients in its at-risk Aetna plans, Alan Lotvin, CVS' chief transformation officer, said in an interview.

  • PR Newswire

    CVS Health Announces $750K in New Funding for California Harm Reduction Coalition

    As part of its commitment to building healthier communities, CVS Health (NYSE: CVS) today announced it will be providing $750,000 over the next three years to the national Harm Reduction Coalition to improve the health and wellness of California residents impacted by prescription opioid misuse and abuse.

  • PR Newswire

    CVS Health Launches Transform Oncology Care™ Program to Help Improve Patient Outcomes and Lower Overall Costs

    CVS Health (NYSE: CVS) today announced Transform Oncology Care™, anchored on a first-of-its-kind precision medicine strategy for payors. The program uses genomic testing results at the point-of-prescribing to help patients start on the best treatment, faster and in addition, matches eligible patients to clinical trials. Transform Oncology Care also uses the Company's local footprint and unique assets to improve patient outcomes and lower overall costs at every point of the cancer care journey.

  • GuruFocus.com

    Sugi Is Thriving in a Growth Industry

    The company continues to open new stores, the industry is growing and consolidation portends good things for the larger players Continue reading...

  • CVS Health Rides on Aetna Prospects, Strong Selling Season
    Zacks

    CVS Health Rides on Aetna Prospects, Strong Selling Season

    CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.

  • The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
    Zacks

    The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman

    The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman

  • Top Stock Reports for Toyota, CVS Health & 3M
    Zacks

    Top Stock Reports for Toyota, CVS Health & 3M

    Top Stock Reports for Toyota, CVS Health & 3M

  • UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
    Zacks

    UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services

    UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.

  • California fines CVS pharmacy chain a record $3.6 million for failing to recycle
    MarketWatch

    California fines CVS pharmacy chain a record $3.6 million for failing to recycle

    California is fining the nation’s largest pharmacy health care provider a record $3.6 million for failing to redeem deposits on bottles and cans at some of its locations, regulators said Monday.

  • Moody's

    Rite Aid Corporation -- Moody's upgrades Rite Aid's PDR to Caa1-PD/LD

    Moody's Investors Service ("Moody's") today upgraded Rite Aid Corporation's ("Rite Aid") Probability of Default rating to Caa1-PD from Caa3-PD and appended the PDR with the "/LD" (limited default) designation. There is no change in the company's SGL-3 speculative grade liquidity rating.

  • CVS Health Completes Rollout of Time Delay Safes in All of Its West Virginia Pharmacies
    PR Newswire

    CVS Health Completes Rollout of Time Delay Safes in All of Its West Virginia Pharmacies

    CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 58 CVS Pharmacy locations in West Virginia, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

  • Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?
    Simply Wall St.

    Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at...

  • 4 Health Care Stocks Gurus Broadly Own
    GuruFocus.com

    4 Health Care Stocks Gurus Broadly Own

    November jobs report shows strong growth in education and health services Continue reading...

  • Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?
    Zacks

    Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?

    CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • 20 businesses that died in the 2010s
    Yahoo Finance

    20 businesses that died in the 2010s

    Yahoo Finance takes a look back at some of the biggest corporate busts of the last decade.

  • Elizabeth Warren Wants to Spoil the Megamerger Party
    Bloomberg

    Elizabeth Warren Wants to Spoil the Megamerger Party

    (Bloomberg Opinion) -- The merger floodgates broke open five years ago, and now U.S. Senator Elizabeth Warren wants to close the hatch. Her proposed bill to substantially restrict big corporate tie-ups is more a presidential campaign statement than viable legislation — and it certainly won’t score her any more points with the Wall Street crowd — but she is calling attention to the maniacal pace of dealmaking in corporate America and the need to modernize antitrust laws that have permitted some recent problematic transactions.More than $7 trillion of takeovers of U.S. companies have been announced since this day in 2014 — 52,694 companies to be exact.(1) That compares with just $4.4 trillion of deals in the previous five-year period. The transactions grew over time as balance sheets flush with cash and income statements desperate for growth created a perfect storm, which more often than not was stoked by pliable regulators. The Walt Disney Co. acquired 21st Century Fox Inc.; Charter Communications Inc. bought Time Warner Cable Inc.; CVS Health Corp. took over Aetna Inc.; Marriott International Inc. merged with Starwood Hotels & Resorts Worldwide Inc.; and T-Mobile US Inc. is trying to buy Sprint Corp. Those are just some of the more recognizable names. Warren, one of the top-polling candidates heading into the Democratic primaries, wants to ban deals in which one company has annual revenue of more than $40 billion, or both businesses generate more than $15 billion in sales, according to a draft of the bill reviewed by Bloomberg News. (A notable exception would be companies facing insolvency.) That could effectively prevent every top airline, insurer, manufacturer, oil producer, retailer, technology platform and other conglomerates — perhaps even Warren Buffett’s M&A vehicle, Berkshire Hathaway Inc. — from making any acquisitions. It would sound the M&A death knell. The idea, however, is unlikely to gain broad support among lawmakers.Even so, it’s hard not to notice the rising drumbeat of politicians concerned about overreach by corporate giants, particularly those in the tech field. Senator Amy Klobuchar, another Democratic presidential candidate, plans to introduce separate antitrust legislation soon, Bloomberg News reported, citing a person familiar with the matter. (Michael Bloomberg, the founder and majority owner of Bloomberg LP, the parent of Bloomberg News and Bloomberg Opinion, is also campaigning for president.)For the Trump administration’s part, the U.S. Justice Department is already investigating whether tech giants — namely Apple Inc., Amazon.com Inc., Facebook Inc. and Google — are using their unchecked power to engage in harmful business practices. But as I wrote in July, if regulators are so concerned about protecting consumers from tech overreach, their glowing endorsement of T-Mobile’s takeover of Sprint is a funny way of showing it; it will shrink the U.S. wireless market from four to three major carriers and remove a company that’s helped to keep customer prices in check.Antitrust regulation under President Donald Trump has at times created questionable optics. Makan Delrahim, the Justice Department’s top antitrust enforcer, seemed to switch his stance on AT&T Inc.’s takeover of Time Warner Inc. as Trump railed against the deal. Time Warner was the parent of CNN, which Trump views as his personal nemesis. (I’ve argued that whatever the case, scrutiny of the megamerger was warranted considering the broad market power it gave to AT&T as media companies without such scale struggle to compete.) By comparison, Disney and Fox, which was controlled by Trump pal Rupert Murdoch, closed their megadeal with few regulatory hiccups. Warren has criticized other giant deals, such as the merger of SunTrust Banks Inc. and BB&T Corp. and the combination of seed makers Bayer AG and Monsanto Co. Given that they aren’t household names, though, most Americans are unfazed by or unaware of such deals, even though they may feel the effects later. Her bill would direct the government to take into account not just whether a merger will lead to higher prices but also what the impact might be on workers, privacy and industry innovation. To justify the cost of buying another large company, dealmakers tend to come up with ambitious estimates of synergies, a euphemism for layoffs. It’s clear that the meaning of “harm” needs to be expanded in the antitrust sense, and laws need to take a more holistic view of the potential consequences of M&A as the lines between industries continue to blur. The Big Tech factor also needs to be weighed, as some deals are being done in part to respond to companies like Amazon that are spreading their tentacles into new areas. On Wednesday, TV-network operators CBS Corp. and Viacom Inc. completed their own merger, a bid to cut costs and create more scale to compete against a new roster of even more powerful media giants: Amazon, Apple, AT&T and Disney. Even then, ViacomCBS Inc., as the merged entity is now called, may not be big enough, and so it may be only a matter of time before it gets swallowed. Warren’s overly broad proposal likely isn’t the answer. But Democrats do seem ready to at least try to rein in a market that’s gotten out of hand. For dealmakers, this may be last call at the M&A party.(1) Data compiled by Bloomberg as of Thursday morning. Excludes terminated deals.To contact the author of this story: Tara Lachapelle at tlachapelle@bloomberg.netTo contact the editor responsible for this story: Daniel Niemi at dniemi1@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tara Lachapelle is a Bloomberg Opinion columnist covering the business of entertainment and telecommunications, as well as broader deals. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.

  • Aetna Foundation Announces $1 Million in Grants to Boys & Girls Clubs in Providence and Hartford
    PR Newswire

    Aetna Foundation Announces $1 Million in Grants to Boys & Girls Clubs in Providence and Hartford

    As part of its commitment to building healthier communities, the Aetna Foundation today announced it will be donating a total of $1 million to the Boys & Girls Clubs of Providence and Hartford. Both locations will receive $500,000 over the next five years.

  • PR Newswire

    CVS Health Announces Successful First Year of Aetna Integration at One Year Anniversary

    CVS Health Corporation (NYSE: CVS) today announced it has successfully completed the first year of combined operations following the acquisition of Aetna in late 2018. The combined company has met or exceeded its first-year integration goals while introducing new, consumer-focused offerings as a result of its unmatched capabilities. CVS Health remains on track to meet its most recent 2019 net synergy guidance and remains confident in its net synergy targets for 2020 and 2021.

  • Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
    Zacks

    Molina Healthcare Wins Kentucky Medicaid Managed Care Deal

    Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.

  • Billions of pain pills were supplied in North Carolina -- here's where they went
    American City Business Journals

    Billions of pain pills were supplied in North Carolina -- here's where they went

    Between 2006 and 2012, the data shows more than 2.5 billion prescription pain pills were supplied to North Carolina.

  • UPS promotes Marken CEO to lead new Healthcare and Life Sciences unit
    American City Business Journals

    UPS promotes Marken CEO to lead new Healthcare and Life Sciences unit

    UPS tapped a leader to oversee the company's new health-care unit that's aimed at pharmaceutical, biopharma and medical device companies.

  • Centene (CNC) Divests IlliniCare as Part of Merger Agreement
    Zacks

    Centene (CNC) Divests IlliniCare as Part of Merger Agreement

    Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.

  • CVS Health Set to Acquire Centene's IlliniCare Health Plan
    Zacks

    CVS Health Set to Acquire Centene's IlliniCare Health Plan

    CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.

  • Retired NFL players accused of $3M health benefits scam
    Yahoo Finance Video

    Retired NFL players accused of $3M health benefits scam

    Ten former NFL players are being accused of scamming the league’s healthcare benefits plan for more than $3 million. Yahoo Sports' Senior Writer Charles Robinson joins Zack Guzman, Emily McCormick and former ‘Bachelorette’ contestant & business consultant Jason Tartick on YFi PM to discuss.